Literature DB >> 2577691

On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration.

A B Jeppsson1, C G Löfdahl, B Waldeck, E Widmark.   

Abstract

Six bronchodilating beta-adrenoceptor agonists, clinically documented with respect to the duration of action after inhalation, were included in this study in vitro on the guinea-pig trachea. Relaxation of carbachol contracted trachea strip preparations and inhibition of contraction of a vagus nerve-tracheal tube preparation were measured. The relaxing effects of salbutamol and fenoterol (both with relatively short duration in man) were rapid in onset and easily reversed by washing in a drug-free medium. The relaxation by salmeterol (long duration) and D2343 (intermediate duration) developed more slowly, resisted washing but was reversed by propranolol. Formoterol (long duration) and salmefamol (intermediate duration) showed properties between these two extremes. All test compounds inhibited the vagally-induced contractions of tracheal concentration dependently. The EC50 values for the hydrophilic compounds salbutamol and fenoterol were higher with intra- as compared with extratracheal administration. For the more lipophilic compounds formoterol, salmefamol, salmeterol and D2343, this difference was less pronounced. A high lipophilicity and a retention by the tissue in vitro of a beta-adrenoceptor agonist may be factors contributing to a long effect duration after inhalation but a further selection has to be made in vivo since metabolic and circulatory effects may influence the effect kinetics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2577691     DOI: 10.1016/0952-0600(89)90028-8

Source DB:  PubMed          Journal:  Pulm Pharmacol        ISSN: 0952-0600


  17 in total

Review 1.  Basic pharmacology of new long-acting sympathomimetics.

Authors:  C G Löfdahl
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 3.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 4.  Dose-response of inhaled drugs in asthma. An update.

Authors:  D J Clark; B J Lipworth
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

5.  Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.

Authors:  A Bergendal; A Lindén; B E Skoogh; M Gerspacher; G P Anderson; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.

Authors:  A Lindén; A Bergendal; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Bambuterol and terbutaline in human cerebrospinal fluid and plasma.

Authors:  B Rosberg; C Schröder; L Nyberg; J Rosenborg; J E Wirén
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.

Authors:  P Anderson; J Lötvall; A Lindén
Journal:  Lung       Date:  1996       Impact factor: 2.584

9.  The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.

Authors:  B L Källström; J Sjöberg; B Waldeck
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 10.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.